Gritstone bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Gritstone bio generated cash of -$121,648,000, which is less than the previous year. Cash used in financing activities reached the amount of $25,117,000 last year. Net change in cash is therefore $5,810,000.
Cash Flow
| 2016 | -15.29M | -32.12M | 35.94M |
|---|---|---|---|
| 2017 | -34.97M | -33.25M | 95.81M |
| 2018 | -38.16M | -59.10M | 110.44M |
| 2019 | -85.01M | 15.84M | 74.39M |
| 2020 | -89.10M | 65.94M | 135.80M |
| 2021 | -50.67M | -118.55M | 108.76M |
| 2022 | -115.94M | -12.96M | 83.09M |
| 2023 | -121.64M | 102.34M | 25.11M |
GRTS Cash Flow Statement (2016 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 59.47M | 110.57M | 171.04M | 58.4M | 53.17M | 39.99M | 12.41M | 23.88M |
Operating activities | ||||||||
Net income | -138.49M | -119.68M | -75.08M | -105.31M | -94.43M | -64.77M | -41.37M | -18.75M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 7.59M | 6.56M | 6.34M | 6.64M | 4.74M | 3.96M | 1.97M | 823K |
Stock-based compensation expense | 11.61M | 12.55M | 10.55M | 7.11M | 5.29M | 0 | 1.12M | 597K |
| Deferred income tax benefit | 11.61M | 12.55M | 10.55M | 7.11M | 5.29M | 0 | 1.12M | 597K |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -1.96M | 1.87M | -419K | 826K | 45K | 3.24M | 2.27M | -760K |
Cash generated by operating activities | -121.64M | -115.94M | -50.67M | -89.10M | -85.01M | -38.16M | -34.97M | -15.29M |
Investing activities | ||||||||
Purchases Of Investments | -26.29M | -141.90M | -199.90M | -8.80M | -80.97M | -102.16M | -63.22M | -47.99M |
Investments In Property Plant And Equipment | -4.57M | -5.87M | -5.46M | -3.51M | -16.17M | -5.66M | -11.52M | -6.98M |
Acquisitions Net | -106.91M | 7.09M | 0 | -69.46M | -32.01M | 0 | 31K | 0 |
Cash generated by investing activities | 102.34M | -12.96M | -118.55M | 65.94M | 15.84M | -59.10M | -33.25M | -32.12M |
Financing activities | ||||||||
Common Stock Issued | 8.09M | 64.73M | 112.88M | 135.90M | 74.32M | 92.58M | 14K | 232K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 19.67M | 18.90M | -56K | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 25.11M | 83.09M | 108.76M | 135.80M | 74.39M | 110.44M | 95.81M | 35.94M |
Net Change In Cash | 5.81M | -45.81M | -60.47M | 112.64M | 5.22M | 13.17M | 27.58M | -11.47M |
Cash at end of period | 65.28M | 64.76M | 110.57M | 171.04M | 58.4M | 53.17M | 39.99M | 12.41M |
| Data source | Data source | Data source | Data source | Data source | Data source |